The University of Melbourne and Australia’s Victoria state government have unveiled the building design and location for the new A$650m Australian Institute for Infectious Disease (AIID).

The AIID will provide quick responses to existing and future infectious diseases and pandemics for Australians.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It will be located at 766–780 Elizabeth Street and 213–223 Berkely Street in the Melbourne biomedical precinct.

The new AIID building will include a human infection challenge unit, high-containment facilities, a robotic biobanking facility, interview rooms, dry laboratories and spaces for community engagement and co-design work.

It will be connected across multiple levels to the University of Melbourne’s Doherty Institute.

The proposed institute will focus on vaccine research, public health research, therapeutics, genomics, diagnostics, clinical trials and data.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Designed by Australian architectural company Wardle, the new institute will be a collaboration between the Doherty Institute and the Burnet Institute. The latter will relocate its headquarters to the new building.

The project is supported by A$400m in funding from the Victorian government and A$250m from three founding partners, namely the Burnet Institute, the Peter Doherty Institute for Infection and Immunity, and the University of Melbourne.

University of Melbourne vice-chancellor Duncan Maskell stated: “We are thrilled to reveal the plans for the new AIID building.

“It will be an iconic addition to the world-leading Melbourne biomedical precinct and will equip us with the facilities and resources we need to get ahead of the next pandemic.”

Demolition of the existing buildings on the site will commence next year, and construction work on the new building will begin in 2025.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now